Impact of immunosuppressive therapy in IgA nephropathy
- Conditions
- N03.3
- Registration Number
- DRKS00025167
- Lead Sponsor
- niversitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 131
Inclusion Criteria
Biopsy-proven IgA nephritis, therapy at the University Hospital of Freiburg between 2000 to 2020
Exclusion Criteria
systemic lupus erythematosus or Henoch-Schonlein Purpura
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Kidney function after five years as assessed by the serum creatinine value.
- Secondary Outcome Measures
Name Time Method proteinuria, hematuria